Cite
MLA Citation
A. Shirahata et al.. “A Phase II clinical trial of a mixture of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics.” Haemophilia, vol. 19, n.d., pp. 853–860. http://access.bl.uk/ark:/81055/vdc_100044393381.0x000001